The Ravetch lab engineered an antibody therapy based on the insight that antibodies containing a specific sugar group, sialic ...
Panelists discuss how SC delivery enhances patient convenience and health care efficiency in NSCLC treatment.
The FDA has approved daratumumab and hyaluronidase-fihj (Darzalex Faspro) for the treatment of adult patients with high-risk ...
The FDA has approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) for use in patients with high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback